Editors: Atta-ur-Rahman, FRS , Prof. Muhammad Iqbal Choudhary

Frontiers in Cardiovascular Drug Discovery

Volume 4

eBook: US $69 Special Offer (PDF + Printed Copy): US $166
Printed Copy: US $131
Library License: US $276
ISSN: 2452-3267 (Print)
ISSN: 1879-6648 (Online)
ISBN: 978-1-68108-400-8 (Print)
ISBN: 978-1-68108-399-5 (Online)
Year of Publication: 2019
DOI: 10.2174/97816810839951180401

Introduction

Frontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The eBook series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.

The fourth volume of the series covers the following topics:

  • - Aspirin administration
  • - Adenosine receptor targeting for cardiovascular therapy
  • - Drug treatment of patients with coronary stenting
  • - Immunosuppressive drugs in heart transplantation
  • - PCSK9 inhibition for lowering LDL-C levels

Contributors

Editor(s):
Atta-ur-Rahman, FRS
University of Cambridge
Kings College
Cambridge
UK


Prof. Muhammad Iqbal Choudhary
International Center for Chemical and Biological Sciences
University of Karachi, Karachi-75270
Pakistan